Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study.

Warris A, Pana ZD, Oletto A, Lundin R, Castagnola E, Lehrnbecher T, Groll AH, Roilides E, Andersen CT, Arendrup MC, Arsenijevic VA, Bianchini S, von Both U, Chmelnik M, Controzzi T, Emonts M, Esposito S, Ferreras-Antolin L, Henriet S, Iosifidis E, Irwin A, Kopsidas J, Lagrou K, Lyall H, Casteleiro AM, Mesini A, Olbrich P, Paulus S, Lausch KR, Soler-Palacin P, Spyridis N, Strenger V, Theodoraki M, Wolfs T; EUROCANDY Study Group**; **EUROCANDY study group:.

Pediatr Infect Dis J. 2019 Nov 8. doi: 10.1097/INF.0000000000002530. [Epub ahead of print]

PMID:
31725552
2.

A decade of enterovirus genetic diversity in Belgium.

Wollants E, Beller L, Beuselinck K, Bloemen M, Lagrou K, Reynders M, Van Ranst M.

J Clin Virol. 2019 Oct 25;121:104205. doi: 10.1016/j.jcv.2019.104205. [Epub ahead of print]

PMID:
31722268
3.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group.

Lancet Infect Dis. 2019 Nov 5. pii: S1473-3099(19)30312-3. doi: 10.1016/S1473-3099(19)30312-3. [Epub ahead of print] Review.

PMID:
31699664
4.

Longitudinal In Vivo Assessment of Host-Microbe Interactions in a Murine Model of Pulmonary Aspergillosis.

Saini S, Poelmans J, Korf H, Dooley JL, Liang S, Manshian BB, Verbeke R, Soenen SJ, Vande Velde G, Lentacker I, Lagrou K, Liston A, Gysemans C, De Smedt SC, Himmelreich U.

iScience. 2019 Oct 25;20:184-194. doi: 10.1016/j.isci.2019.09.022. Epub 2019 Sep 18.

5.

Infectious disease consultation lowers candidaemia mortality.

Lagrou K, Van Wijngaerden E.

Lancet Infect Dis. 2019 Sep 24. pii: S1473-3099(19)30522-5. doi: 10.1016/S1473-3099(19)30522-5. [Epub ahead of print] No abstract available.

PMID:
31562023
6.

Hospital Laboratory Survey for Identification of Candida auris in Belgium.

Dewaele K, Lagrou K, Frans J, Hayette MP, Vernelen K.

J Fungi (Basel). 2019 Sep 5;5(3). pii: E84. doi: 10.3390/jof5030084.

7.

Pathogenesis and management of fracture-related infection.

Depypere M, Morgenstern M, Kuehl R, Senneville E, Moriarty TF, Obremskey WT, Zimmerli W, Trampuz A, Lagrou K, Metsemakers WJ.

Clin Microbiol Infect. 2019 Aug 22. pii: S1198-743X(19)30447-1. doi: 10.1016/j.cmi.2019.08.006. [Epub ahead of print] Review.

PMID:
31446152
8.

Gliotoxin and bis(methylthio)gliotoxin are not reliable as biomarkers of invasive aspergillosis.

Mercier T, Reséndiz Sharpe A, Waumans D, Desmet K, Lagrou K, Maertens J.

Mycoses. 2019 Oct;62(10):945-948. doi: 10.1111/myc.12967. Epub 2019 Aug 12.

PMID:
31313395
9.

Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study.

Mercier T, Dunbar A, de Kort E, Schauwvlieghe A, Reynders M, Guldentops E, Blijlevens NMA, Vonk AG, Rijnders B, Verweij PE, Lagrou K, Maertens J.

Med Mycol. 2019 Jul 9. pii: myz079. doi: 10.1093/mmy/myz079. [Epub ahead of print]

PMID:
31290552
10.

ECMM CandiReg-A ready to use platform for outbreaks and epidemiological studies.

Koehler P, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bretagne S, Klingspor L, Lagrou K, Meis JF, Rautemaa-Richardson R, Schelenz S, Hamprecht A, Koehler FC, Kurzai O, Salmanton-García J, Vehreschild JJ, Alanio A, Alastruey-Izquierdo A, Arsic Arsenijevic V, Gangneux JP, Gow NAR, Hadina S, Hamal P, Johnson E, Klimko N, Lass-Flörl C, Mares M, Özenci V, Papp T, Roilides E, Sabino R, Segal E, Talento AF, Tortorano AM, Verweij PE, Hoenigl M, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2019 Oct;62(10):920-927. doi: 10.1111/myc.12963. Epub 2019 Aug 1.

PMID:
31271702
11.

Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.

Resendiz-Sharpe A, Mercier T, Lestrade PPA, van der Beek MT, von dem Borne PA, Cornelissen JJ, De Kort E, Rijnders BJA, Schauwvlieghe AFAD, Verweij PE, Maertens J, Lagrou K.

J Antimicrob Chemother. 2019 Sep 1;74(9):2759-2766. doi: 10.1093/jac/dkz258.

PMID:
31236587
12.

Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspective.

Lagrou K, Duarte RF, Maertens J.

J Antimicrob Chemother. 2019 Mar 1;74(Supplement_2):ii3-ii8. doi: 10.1093/jac/dkz037.

PMID:
31222311
13.

Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss.

Andrei G, Van Loon E, Lerut E, Victoor J, Meijers B, Bammens B, Sprangers B, Gillemot S, Fiten P, Opdenakker G, Lagrou K, Kuypers D, Snoeck R, Naesens M.

Antiviral Res. 2019 Aug;168:203-209. doi: 10.1016/j.antiviral.2019.06.004. Epub 2019 Jun 15.

PMID:
31212020
14.

Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.

Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Carannante N, Carnelutti A, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Le Bihan C, Luzzati R, Malbrain MLNG, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Peghin M, Raineri SM, Rautemaa-Richardson R, Schouten J, Brugnaro P, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Montravers P.

Crit Care. 2019 Jun 14;23(1):219. doi: 10.1186/s13054-019-2497-3.

15.

Sensitive bioluminescence imaging of fungal dissemination to the brain in mouse models of cryptococcosis.

Vanherp L, Ristani A, Poelmans J, Hillen A, Lagrou K, Janbon G, Brock M, Himmelreich U, Vande Velde G.

Dis Model Mech. 2019 Jun 17;12(6). pii: dmm039123. doi: 10.1242/dmm.039123.

16.

Migrating a lab-developed MERS-CoV real-time PCR to 3 "Sample to Result" systems: experiences on optimization and validation.

Frans G, Beuselinck K, Peeters B, Van Ranst M, Saegeman V, Desmet S, Lagrou K.

Diagn Microbiol Infect Dis. 2019 Aug;94(4):349-354. doi: 10.1016/j.diagmicrobio.2019.02.006. Epub 2019 Feb 10.

PMID:
30929995
17.

Beta-d-Glucan for Diagnosing Pneumocystis Pneumonia: a Direct Comparison between the Wako β-Glucan Assay and the Fungitell Assay.

Mercier T, Guldentops E, Patteet S, Beuselinck K, Lagrou K, Maertens J.

J Clin Microbiol. 2019 May 24;57(6). pii: e00322-19. doi: 10.1128/JCM.00322-19. Print 2019 Jun.

PMID:
30918045
18.

Systemic antifungal drug use in Belgium-One of the biggest antifungal consumers in Europe.

Goemaere B, Lagrou K, Spriet I, Hendrickx M, Vandael E, Becker P, Catry B.

Mycoses. 2019 Jun;62(6):542-550. doi: 10.1111/myc.12912. Epub 2019 Apr 7.

PMID:
30887582
19.

Clinical and biochemical differences between hantavirus infection and leptospirosis: a retrospective analysis of a patient series in Belgium.

Bakelants E, Peetermans W, Lagrou K, Meersseman W.

Acta Clin Belg. 2019 Mar 18:1-8. doi: 10.1080/17843286.2019.1591654. [Epub ahead of print]

PMID:
30882283
20.

Clostridium difficile infection in inflammatory bowel disease: epidemiology over two decades.

Moens A, Verstockt B, Machiels K, Bossuyt P, Verdonck A, Lagrou K, van Assche G, Vermeire S, Ferrante M.

Eur J Gastroenterol Hepatol. 2019 Jun;31(6):668-673. doi: 10.1097/MEG.0000000000001394.

PMID:
30839436
21.

Development and validation of the European QUALity (EQUAL) score for mucormycosis management in haematology.

Koehler P, Mellinghoff SC, Lagrou K, Alanio A, Arenz D, Hoenigl M, Koehler FC, Lass-Flörl C, Meis JF, Richardson M, Cornely OA.

J Antimicrob Chemother. 2019 Jun 1;74(6):1704-1712. doi: 10.1093/jac/dkz051.

PMID:
30770712
22.

Corrigendum: Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Sabino R, Lass-Flörl C, Lackner M.

Front Microbiol. 2019 Jan 14;9:3245. doi: 10.3389/fmicb.2018.03245. eCollection 2018.

23.

Comment on: Improving access to appropriate post-exposure doxycycline for Lyme disease prophylaxis: role for community pharmacies.

Lagrou K, Peetermans W, De Munter P.

J Antimicrob Chemother. 2019 May 1;74(5):1464-1465. doi: 10.1093/jac/dky570. No abstract available.

PMID:
30689906
24.

Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.

Mercier T, Schauwvlieghe A, de Kort E, Dunbar A, Reynders M, Guldentops E, Rijnders B, Verweij PE, Lagrou K, Maertens J.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01913-18. doi: 10.1128/JCM.01913-18. Print 2019 Apr.

25.

Letermovir for prophylaxis of cytomegalovirus manifestations in adult allogeneic hematopoietic stem cell transplant recipients.

Hecke SV, Calcoen B, Lagrou K, Maertens J.

Future Microbiol. 2019 Feb;14:175-184. doi: 10.2217/fmb-2018-0250. Epub 2019 Jan 15.

PMID:
30644320
26.

Active neuroborreliosis or inflammation: are the diagnostic guidelines at stake?

De Cauwer H, Lagrou K, Coeckelbergh E, Bogaerts A, Leenders J, Vanneste D.

Acta Neurol Belg. 2019 Jun;119(2):207-214. doi: 10.1007/s13760-018-01067-2. Epub 2018 Dec 17.

PMID:
30556097
27.

Distribution of HCV genotypes in Belgium from 2008 to 2015.

Bouacida L, Suin V, Hutse V, Boudewijns M, Cartuyvels R, Debaisieux L, De Laere E, Hallin M, Hougardy N, Lagrou K, Oris E, Padalko E, Reynders M, Roussel G, Senterre JM, Stalpaert M, Ursi D, Vael C, Vaira D, Van Acker J, Verstrepen W, Van Gucht S, Kabamba B, Quoilin S, Muyldermans G.

PLoS One. 2018 Dec 5;13(12):e0207584. doi: 10.1371/journal.pone.0207584. eCollection 2018.

28.

First case of Candida auris infection in Belgium in a surgical patient from Kuwait.

Dewaele K, Frans J, Smismans A, Ho E, Tollens T, Lagrou K.

Acta Clin Belg. 2018 Dec 4:1-8. doi: 10.1080/17843286.2018.1555114. [Epub ahead of print]

PMID:
30514182
29.

Use of Next-Generation Sequencing for Diagnosis of West Nile Virus Infection in Patient Returning to Belgium from Hungary.

Wollants E, Smolders D, Naesens R, Bruynseels P, Lagrou K, Matthijnssens J, Van Ranst M.

Emerg Infect Dis. 2018 Dec;24(12):2380-2382. doi: 10.3201/eid2412.180494.

30.

Monitoring of Fluconazole and Caspofungin Activity against In Vivo Candida glabrata Biofilms by Bioluminescence Imaging.

Persyn A, Rogiers O, Brock M, Vande Velde G, Lamkanfi M, Jacobsen ID, Himmelreich U, Lagrou K, Van Dijck P, Kucharíková S.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01555-18. doi: 10.1128/AAC.01555-18. Print 2019 Feb.

31.

Correction to: Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations.

Padalko E, Lagrou K, Delforge ML, Jansens H, Ectors N, Pirnay JP, Klykens J, Sokal E, Muylle L, Libois A, Vanderkelen A, Verbeken G, Matthys C, Goossens D, Hanssens G, Baltes M, Beele H.

Cell Tissue Bank. 2018 Dec;19(4):835-836. doi: 10.1007/s10561-018-9728-8.

32.

Prevalence, geographic risk factor, and development of a standardized protocol for fungal isolation in cystic fibrosis: Results from the international prospective study "MFIP".

Delhaes L, Touati K, Faure-Cognet O, Cornet M, Botterel F, Dannaoui E, Morio F, Le Pape P, Grenouillet F, Favennec L, Le Gal S, Nevez G, Duhamel A, Borman A, Saegeman V, Lagrou K, Gomez E, Carro ML, Canton R, Campana S, Buzina W, Chen S, Meyer W, Roilides E, Simitsopoulou M, Manso E, Cariani L, Biffi A, Fiscarelli E, Ricciotti G, Pihet M, Bouchara JP.

J Cyst Fibros. 2019 Mar;18(2):212-220. doi: 10.1016/j.jcf.2018.10.001. Epub 2018 Oct 20. No abstract available.

PMID:
30348610
33.

Biological tests carried out on serum/plasma samples from donors of human body material for transplantation: Belgian experience and practical recommendations.

Padalko E, Lagrou K, Delforge ML, Jansens H, Ectors N, Pirnay JP, Klykens J, Sokal E, Muylle L, Libois A, Vanderkelen A, Verbeken G, Matthys C, Goossens D, Hanssens G, Baltes M, Beele H.

Cell Tissue Bank. 2018 Dec;19(4):681-695. doi: 10.1007/s10561-018-9721-2. Epub 2018 Aug 29. Erratum in: Cell Tissue Bank. 2018 Oct 26;:.

34.

Switch in childhood pneumococcal vaccine in Belgium.

Desmet S, Peetermans W, Lagrou K.

Lancet Infect Dis. 2018 Sep;18(9):945-946. doi: 10.1016/S1473-3099(18)30484-5. No abstract available.

PMID:
30152356
35.

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Hoenigl M, Gangneux JP, Segal E, Alanio A, Chakrabarti A, Chen SC, Govender N, Hagen F, Klimko N, Meis JF, Pasqualotto AC, Seidel D, Walsh TJ, Lagrou K, Lass-Flörl C, Cornely OA; European Confederation of Medical Mycology (ECMM).

Mycoses. 2018 Nov;61(11):885-894. doi: 10.1111/myc.12836. Epub 2018 Aug 28.

PMID:
30086186
36.

Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.

Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans DCJJ, Hoedemaekers A, Andrinopoulou ER, van den Berg CHSB, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, Wauters J; Dutch-Belgian Mycosis study group.

Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.

PMID:
30076119
37.

Anidulafungin increases the antibacterial activity of tigecycline in polymicrobial Candida albicans/Staphylococcus aureus biofilms on intraperitoneally implanted foreign bodies.

Rogiers O, Holtappels M, Siala W, Lamkanfi M, Van Bambeke F, Lagrou K, Van Dijck P, Kucharíková S.

J Antimicrob Chemother. 2018 Oct 1;73(10):2806-2814. doi: 10.1093/jac/dky246.

PMID:
30010876
38.

Switch in a childhood pneumococcal vaccination programme from PCV13 to PCV10: a defendable approach?

Desmet S, Verhaegen J, Van Ranst M, Peetermans W, Lagrou K.

Lancet Infect Dis. 2018 Aug;18(8):830-831. doi: 10.1016/S1473-3099(18)30346-3. Epub 2018 Jul 11. No abstract available.

PMID:
30001857
39.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

40.

Genetic deficiency of NOD2 confers resistance to invasive aspergillosis.

Gresnigt MS, Cunha C, Jaeger M, Gonçalves SM, Malireddi RKS, Ammerdorffer A, Lubbers R, Oosting M, Rasid O, Jouvion G, Fitting C, Jong DJ, Lacerda JF, Campos A Jr, Melchers WJG, Lagrou K, Maertens J, Kanneganti TD, Carvalho A, Ibrahim-Granet O, van de Veerdonk FL.

Nat Commun. 2018 Jul 6;9(1):2636. doi: 10.1038/s41467-018-04912-3.

41.

Multicentre validation of 4-well azole agar plates as a screening method for detection of clinically relevant azole-resistant Aspergillus fumigatus.

Arendrup MC, Verweij PE, Mouton JW, Lagrou K, Meletiadis J.

J Antimicrob Chemother. 2018 Aug 1;73(8):2274. doi: 10.1093/jac/dky218. No abstract available.

PMID:
29800383
42.

Clonal Spread of Candida glabrata Bloodstream Isolates and Fluconazole Resistance Affected by Prolonged Exposure: a 12-Year Single-Center Study in Belgium.

Goemaere B, Lagrou K, Spriet I, Hendrickx M, Becker P.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00591-18. doi: 10.1128/AAC.00591-18. Print 2018 Aug.

43.

A Multimodal Imaging Approach Enables In Vivo Assessment of Antifungal Treatment in a Mouse Model of Invasive Pulmonary Aspergillosis.

Poelmans J, Himmelreich U, Vanherp L, Zhai L, Hillen A, Holvoet B, Belderbos S, Brock M, Maertens J, Vande Velde G, Lagrou K.

Antimicrob Agents Chemother. 2018 Jun 26;62(7). pii: e00240-18. doi: 10.1128/AAC.00240-18. Print 2018 Jul.

44.

Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.

Mercier T, Guldentops E, Lagrou K, Maertens J.

Front Microbiol. 2018 Apr 4;9:661. doi: 10.3389/fmicb.2018.00661. eCollection 2018. Review.

45.

Azole-Resistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon?

Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M.

Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. Erratum in: Front Microbiol. 2019 Jan 14;9:3245.

46.

A Framework for Understanding the Evasion of Host Immunity by Candida Biofilms.

Garcia-Perez JE, Mathé L, Humblet-Baron S, Braem A, Lagrou K, Van Dijck P, Liston A.

Front Immunol. 2018 Mar 16;9:538. doi: 10.3389/fimmu.2018.00538. eCollection 2018.

47.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

48.

Triazole resistance surveillance in Aspergillus fumigatus.

Resendiz Sharpe A, Lagrou K, Meis JF, Chowdhary A, Lockhart SR, Verweij PE; ISHAM/ECMM Aspergillus Resistance Surveillance working group.

Med Mycol. 2018 Apr 1;56(suppl_1):83-92. doi: 10.1093/mmy/myx144. Review.

PMID:
29538741
49.

Bronchoscopic fibered confocal fluorescence microscopy for longitudinal in vivo assessment of pulmonary fungal infections in free-breathing mice.

Vanherp L, Poelmans J, Hillen A, Govaerts K, Belderbos S, Buelens T, Lagrou K, Himmelreich U, Vande Velde G.

Sci Rep. 2018 Feb 14;8(1):3009. doi: 10.1038/s41598-018-20545-4.

50.

Aspergillus fumigatus Detection and Risk Factors in Patients with COPD-Bronchiectasis Overlap.

Everaerts S, Lagrou K, Vermeersch K, Dupont LJ, Vanaudenaerde BM, Janssens W.

Int J Mol Sci. 2018 Feb 9;19(2). pii: E523. doi: 10.3390/ijms19020523.

Supplemental Content

Loading ...
Support Center